missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ TOM1L2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA554753
This item is not returnable.
View return policy
Description
Immunogen sequence: LLHVNDDLNN VFLRYERFER YRSGRSVQNA SNGVLNEVTE DNLIDLGPGS PAVVSPMVGN TAPPSSLSSQ LAGLDLGTES VSGTLSSLQQ CNPRDGF Highest antigen sequence identity to the following orthologs: Mouse - 96%, Rat - 96%.
This gene belongs to a small gene family whose members have an N-terminal VHS domain followed by a GAT domain; domains which typically participate in vesicular trafficking. The canonical protein encoded by this gene also has a C-terminal clathrin binding motif. This protein has been shown to interact with Tollip, clathrin and ubiquitin and is thought to play a role in endosomal sorting. This gene resides in the 3.7 Mb deletion of chromosome region 17p11.2 that is associated with Smith-Magenis syndrome. Alternative splicing results in multiple transcript variants encoding distinct proteins.
Specifications
| TOM1L2 | |
| Polyclonal | |
| Unconjugated | |
| TOM1L2 | |
| 2900016I08Rik; A730055F12Rik; AU042072; FLJ32746; myb1-like protein 2; Srebf1; target of myb1 like 2 membrane trafficking protein; target of myb1-like 2; target of myb1-like 2 (chicken); Target of Myb-like protein 2; Tom1l2; TOM1-like protein 2; UNQ3124 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 146691 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Immunocytochemistry | |
| 0.05 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q6ZVM7 | |
| TOM1L2 | |
| Recombinant protein corresponding to Human TOM1L2. Recombinant protein control fragment (Product #RP-93433). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction